{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:51:43Z","timestamp":1785855103234,"version":"3.56.0"},"reference-count":86,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>While access to pre-exposure prophylaxis (PrEP) is an important tool for reducing HIV incidence in the United States, disparities in uptake by race, sex, socioeconomic status, and geography persist. In 2018, the US South accounted for more than half of all new HIV diagnoses but only one-third of PrEP users. PrEP use in North Carolina (NC) similarly lags, with uptake being the lowest among young, sexual and gender minority populations, who account for nearly two-thirds of the state\u2019s incident infections. The PrEP-to-need ratio, a metric of PrEP equity that measures PrEP uptake relative to new HIV diagnoses, highlights disparities in PrEP uptake among specific demographic groups such as women and Black, Hispanic, and Southern people, indicating that these groups are underserved relative to their epidemic need. Despite behavioral risk overlap of incident sexually transmitted infections (STIs) and HIV, in NC, PrEP is only offered at a few primarily urban health department\u2013affiliated STI clinics. The lack of robust health care infrastructure in these areas presents challenges for HIV prevention services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This protocol describes a randomized controlled trial of a multilevel PrEP intervention recruiting from rural and periurban STI clinics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This trial aims to enroll up to 336 participants and randomly assign them 1:1 to either the intervention or control group. The intervention consists of access to a digital health app, linkage to a remote PrEP navigator, and the option of referral to telehealth-based PrEP services. Persons randomly assigned to the control condition will receive an enhanced standard of care, including access to a limited version of the digital health app. All participants will be followed up on quarterly for at least 3 months. The primary outcome is the initiation of PrEP within 3 months of an index STI clinic visit; secondary outcomes evaluate PrEP care engagement and adherence, incident HIV and bacterial STI infections, PrEP stigma, and cost-effectiveness. Binary outcome analyses will estimate the proportion of participants achieving an event (eg, PrEP uptake) in each arm and a probability difference and the corresponding 95% CI to compare the intervention versus control arm at each time point. Continuous end points will use nonparametric Wilcoxon rank sum tests comparing the intervention and control groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Enrollment opened on August 31, 2023, at 15 health departments in NC and subsequently expanded to 21 facilities in 20 counties by July 2024. Completion of the enrollment and data collection phases is expected by May 2025. Results will be published thereafter.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study directly addresses multiple barriers to PrEP use in rural and periurban areas of the Southeastern United States and can inform policy and programming that seek to expand PrEP access and promote use in underserved communities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov NCT05984030; https:\/\/clinicaltrials.gov\/study\/NCT05984030<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>International Registered Report Identifier (IRRID)<\/jats:title>\n                    <jats:p>DERR1-10.2196\/68085<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/68085","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T13:07:43Z","timestamp":1736773663000},"page":"e68085","source":"Crossref","is-referenced-by-count":0,"title":["Multilevel Intervention to Support Tailored and Responsive HIV Pre-Exposure Prophylaxis Care in Rural North Carolina: Protocol for a Randomized Controlled Trial"],"prefix":"10.2196","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1571-6576","authenticated-orcid":false,"given":"Sarah E","family":"Rutstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3955-3349","authenticated-orcid":false,"given":"Ella","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3291-1330","authenticated-orcid":false,"given":"Odai","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2486-2583","authenticated-orcid":false,"given":"Nicole","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3067-4324","authenticated-orcid":false,"given":"Jacob B","family":"Stocks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8210-0895","authenticated-orcid":false,"given":"Anja","family":"Washington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4702-4467","authenticated-orcid":false,"given":"Victoria","family":"Mobley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3610-0624","authenticated-orcid":false,"given":"Shannon","family":"Dowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1741-335X","authenticated-orcid":false,"given":"Jessie","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2421-923X","authenticated-orcid":false,"given":"Lisa B","family":"Hightow-Weidman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3290-8200","authenticated-orcid":false,"given":"Christopher B","family":"Hurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7321-9538","authenticated-orcid":false,"given":"Brian","family":"Pence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8522-3240","authenticated-orcid":false,"given":"Kathryn E","family":"Muessig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6446a4"},{"key":"ref2","unstructured":"Fast facts: HIV in the US by ageCenters for Disease Control and Prevention2024-10-08https:\/\/www.cdc.gov\/hiv\/data-research\/facts-stats\/age.html?CDC_AAref_Val=https:\/\/www.cdc.gov\/hiv\/group\/age\/viral-suppression.html"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2105\/ajph.2019.305172"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2021.09.006"},{"key":"ref5","unstructured":"Core indicators for monitoring the ending the HIV epidemic initiative (preliminary data): national HIV surveillance system data reported through June 2023; and preexposure prophylaxis (PrEP) data reported through March 2023. HIV surveillance data tables 2023;4(3). Table 3a. Number of persons prescribed PrEP, number of persons with PrEP indications, and PrEP coverage during January 2019 through March 2023, among persons aged >= 16 Years, by selected characteristics - United States (preliminary)Centers for Disease Control and Prevention20232024-04-29https:\/\/www.cdc.gov\/hiv\/library\/reports\/surveillance-data-tables\/vol-4-no-3\/index.html"},{"key":"ref6","unstructured":"Understanding the current HIV epidemic in the United StatesAIDSVu2023-12-06https:\/\/aidsvu.org\/local-data\/united-states\/south\/"},{"key":"ref7","unstructured":"HIV Surveillance Report, 2021. Vol 34Centers for Disease Control and Prevention20212024-04-29https:\/\/stacks.cdc.gov\/view\/cdc\/149071\/cdc_149071_DS1.pdf"},{"key":"ref8","unstructured":"Monitoring selected national HIV prevention and care objectives by using HIV surveillance data United States and 6 dependent areas, 2018Centers for Disease Control and Prevention20232024-04-29https:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance\/vol-28-no-4\/content\/tables.html"},{"key":"ref9","unstructured":"Core Indicators for Monitoring the Ending the HIV Epidemic Initiative (Preliminary Data): National HIV Surveillance System Data Reported through June 2023; and Preexposure Prophylaxis (PrEP) Data Reported through March 2023. HIV Surveillance Data Tables 2023;4(3). Table 3b. Number of Persons Prescribed PrEP, Number of Persons with PrEP Indications, and PrEP Coverage During January 2019 through March 2023, among Persons Aged \u2265 16 Years, by Area of Residence - United States and Puerto Rico (Preliminary)Centers for Disease Control and Prevention20232024-04-29https:\/\/www.cdc.gov\/hiv\/library\/reports\/surveillance-data-tables\/vol-4-no-3\/index.html"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2017.02.003"},{"key":"ref11","unstructured":"2022 North Carolina STD surveillance report. Table 2. Newly diagnosed HIV rates among adults and adolescents in North Carolina by county of diagnosis, year of diagnosis, and rank order, 2020-2022. North Carolina Department of Health and Human Services, Division of Public Health, communicable disease branchCenters for Disease Control and Prevention20232024-07-29https:\/\/epi.dph.ncdhhs.gov\/cd\/stds\/annualrpts.html"},{"key":"ref12","unstructured":"Occupational employment and wage statistics: May 2022 metropolitan and nonmetropolitan area definitionsU.S. Bureau of Labor Statistics2023-11-15https:\/\/www.bls.gov\/oes\/current\/msa_def.htm"},{"key":"ref13","unstructured":"2022 North Carolina STD surveillance report. North Carolina Department of Health and Human Services, Division of Public Health, Communicable Disease BranchNorth Carolina HIV\/STD\/Hepatitis Surveillance Unit20232024-07-29https:\/\/epi.dph.ncdhhs.gov\/cd\/stds\/figures\/2022-STDSurveillanceReportSummary.pdf"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/003335491613100126"},{"key":"ref15","unstructured":"Tarek MikatiKJImmediate PrEP initiation at New York city sexual health clinicsCROI Foundation\/IAS-USA20192024-04-29https:\/\/www.croiconference.org\/abstract\/immediate-prep-initiation-new-york-city-sexual-health-clinics\/"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000514"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz310"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-13-168"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czq060"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2196\/10444"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000690"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnma.2017.12.006"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/v15061365"},{"key":"ref24","unstructured":"Data access - urban rural classification scheme for countiesCenters for Disease Control and Prevention2023-12-06https:\/\/www.cdc.gov\/nchs\/data_access\/urban_rural.htm"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.4683"},{"key":"ref26","unstructured":"NC ending HIV :a plan to end HIV together, community-by-community, hand-in-handNC Department of Health and Human Services, Division of Public Health20212024-04-29https:\/\/play.google.com\/store\/books\/details?id=yEWTzgEACAAJ"},{"key":"ref27","unstructured":"Local data: North CarolinaAIDSVu20202024-04-29https:\/\/aidsvu.org\/local-data\/united-states\/south\/north-carolina\/#hiv-prevalence"},{"key":"ref28","unstructured":"US public health service: preexposure prophylaxis for the prevention of HIV infection in the United States-2017 update: a clinical practice guidelineCenters for Disease Control and Prevention20182024-04-29https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-guidelines-2017.pdf"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000087"},{"key":"ref30","unstructured":"MuessigKEVecchioACHarrisonSEPatonMPereiraNMPoteatTHansonLAHightow-WeidmanLBEnding the HIV epidemic in the Carolinas: building diverse organizational networks to design and deliver research-tested interventions at the community levelUNC School of Medicine20212024-04-29https:\/\/img1.wsimg.com\/blobby\/go\/18be2c22-c9b5-4536-ad0c-458ac9dcdd6f\/Agenda%20and%20Abstracts_2021%20National%20LGBTQ%20Healt.pdf"},{"key":"ref31","unstructured":"VecchioACMuessigKEHarrisonSEPatonMMcGeeDSoberanoZHightow-WeidmanLEnding the HIV epidemic: creating a unified stigma-informed recruitment campaign to engage youth in HIV prevention. Presented at: national LGBTQ health conferenceProceedings of the 2021 National LGBTQ Health Conference2021LGBTQ '21May 20-21, 2021Virtual Event"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.21037\/mhealth-20-43"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001546"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.13285"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2022.306793"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.evalprogplan.2021.101966"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002274"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-022-03931-y"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.2196\/10174"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000401"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-015-0280-x"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-018-2289-9"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-019-00430-z"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy529"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.2196\/37479"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001873"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.2196\/47932"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1097\/JNC.0000000000000437"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13999-9"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7004a1"},{"key":"ref51","unstructured":"Screening recommendations and considerations referenced in treatment guidelines and original sourcesCenters for Disease Control and Prevention20222024-04-29https:\/\/www.cdc.gov\/std\/treatment-guidelines\/screening-recommendations.htm"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1177\/1090198114562043"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1521\/aeap.2011.23.1.1"},{"issue":"3","key":"ref54","first-page":"164","volume":"6","author":"Muessig, KE","year":"2014","journal-title":"Digit Cult Educ"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2018.1492695"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-018-2256-5"},{"key":"ref57","unstructured":"Division of AIDS (DAIDS) site clinical operations and research essentials (SCORE) manualNational Institute of Allergy and Infectious Diseases2023-12-08https:\/\/www.niaid.nih.gov\/research\/daids-score-manual"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2017.10.030"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01710-17"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-4-67"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-6-78"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-7-41"},{"key":"ref65","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195108248.001.0001","author":"Gold, MR","year":"1996","journal-title":"Cost-Effectiveness in Health and Medicine. 2nd edition"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/s0738-3991(98)00107-4"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1002\/nur.4770140115"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1007\/s10865-016-9770-6"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-018-2159-5"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-020-00533-y"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-020-03110-x"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.30806"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.8.4.e27"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/0149-7189(79)90094-6"},{"key":"ref75","first-page":"189","author":"Brooke, J","year":"1996","journal-title":"Usability Evaluation In Industry"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-9-7"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-013-0469-1"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.2196\/10365"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-13-235"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1080\/08964289.2016.1189396"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X09344747"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2015.09.025"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-1-8"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X03255922"},{"key":"ref85","unstructured":"Defining the role of authors and contributorsInternational Committee of Medical Journal Editors2023-12-08https:\/\/www.icmje.org\/recommendations\/browse\/roles-and-responsibilities\/defining-the-role-of-authors-and-contributors.html"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab466.1047"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2025\/1\/e68085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:00:57Z","timestamp":1785852057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2025\/1\/e68085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":86,"URL":"https:\/\/doi.org\/10.2196\/68085","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.68085","asserted-by":"object"}]},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]}}}